The restructuring of mobile imaging firm Maxum Health resulted in the Dallas-based company postinga net profit of $4.2 million for fiscal 1994 (end-December). Maxumsaid it restructured most of its debt and leasing arrangementsin 1994 and entered into a
The restructuring of mobile imaging firm Maxum Health resulted in the Dallas-based company postinga net profit of $4.2 million for fiscal 1994 (end-December). Maxumsaid it restructured most of its debt and leasing arrangementsin 1994 and entered into a long-term contract with hospital giantColumbia/HCA to run an outpatient imaging center. Maxum beganthe restructuring effort in 1993 (SCAN 3/24/93).
Maxum posted year-end revenues of $45.9 million, up slightlyfrom $45.1 million the year before. The company's net income of$4.2 million represented a major turnaround from the $6.8 millionnet loss recorded in 1993. Much of Maxum's improvement in profitabilitywas attributable to several extraordinary gains, including $3.3million related to extinguishment of debt and $5 million for thesale of its lithotripsy partnership interests. The firm's operatingloss for 1994 stood at $2.8 million, compared to a $6 millionoperating loss in 1993.
Maxum earlier this year partnered with Columbia/HCA to purchaseArlington Diagnostic and Imaging Center in Arlington, VA. Thecenter is jointly owned by the two companies, with Maxum responsiblefor staffing and management.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.